We hypothesized that, in NAFLD/NASH, increased expression of miR-650 upregulates both FOXA2 and TEAD2 mRNAs and downregulates LATS2 mRNA. Here, LATS2 is linked to metabolic dysfunction-associated steatotic liver disease.